Synonyms: CFT-8634
Compound class:
Synthetic organic
Comment: CFT8634 is an orally bioavailable BRD9 degrader that was developed by C4 Therapeutics for potential to treat BRD9-dependent tumours. BRD9 degradation is predicted to offer a more effective option than BRD9 inhibition. Its chemical structure was disclosed at the AACR spring meeting in 2022.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Ligand families/groups | PROTACs, molecular glues and other degraders |
Synonyms ![]() |
CFT-8634 |
Database Links ![]() |
|
CAS Registry No. | 2704617-96-7 (source: PubChem) |
GtoPdb PubChem SID | 464244106 |
PubChem CID | 163322333 |
Search Google for chemical match using the InChIKey | GNRGNRCQXHMQQV-CPBHLAHYSA-N |
Search Google for chemicals with the same backbone | GNRGNRCQXHMQQV |
UniChem Compound Search for chemical match using the InChIKey | GNRGNRCQXHMQQV-CPBHLAHYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | GNRGNRCQXHMQQV-CPBHLAHYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖